AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 136 min read$ISSC

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC): Results of Operations and Financial Condition

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2623046d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 INNOVATIVE AEROSYSTEMS REPORTS THIRD QUARTER FISCAL 2026 RESULTS Exton, PA, August 13, 2026 – Innovative Solutions & Support, Inc. (Nasdaq: ISSC) dba Innovative Aerosystems and its subsidiaries (“IA”) or the "Company", a

Original reporting
SEC EDGAR 8-K
Published Aug 13, 2026, 1:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 1:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$ISSC
Bullish
medium confidence
Mentioned
$ISSC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ISSCBullishMed
01

Why it matters

Traders can update valuation and near-term positioning based on the quantified earnings and cash-flow improvements, backlog level, and liquidity/net-debt metrics, plus corporate actions (ticker change) and strategic progress (Aydin Displays acquisition, eVTOL display/avionics agreement).

02

Market read

Fresh Q3 earnings and cash-flow metrics, plus backlog and liquidity, provide a concrete basis for re-rating ISSC’s near-term fundamentals.

03

What to watch

Backlog is $82.9M and includes exclusions for potential sole-source future orders; also, elevated F-16 revenues in the prior-year comp were affected by manufacturing transition, which may distort normalized comparisons.

Relevance 7/10Novelty 8/10Timing: filed pre-market today (Aug 13, 2026) with Q3 fiscal results and balance-sheet updates

Background

Innovative Solutions & Support, Inc. (dba Innovative Aerosystems) filed an 8-K with Exhibit 99.1 reporting fiscal 2026 third-quarter results and related financial condition updates.

Company-level read

Ticker impact

$ISSCBullishMedium confidence
Context

ISSC reported fiscal 2026 Q3 results, including net sales of $26.7M (+10.7%) and gross margin of 51.7%, plus $12.3M YTD free cash flow.

Expected impact

Likely modest positive bias for the next session as traders digest improved margins, cash generation, and backlog, though magnitude depends on Street expectations.

Evidence & confidence

This is a primary 8-K earnings release with multiple quantified improvements (revenue, margin, adjusted EBITDA, free cash flow) and balance-sheet liquidity (cash $53.7M, net debt/TTM adj EBITDA 1.4x).

Market effects

Sector

Signals improving profitability and cash generation in advanced avionics, potentially supporting sentiment toward small-cap defense-adjacent suppliers.

Regional

No clear regional read-through beyond Exton facility transition mentioned.

Global

Limited global impact; includes a Japanese eVTOL design agreement and military-related backlog, but no cross-border financial guidance disclosed.

Counterpoint

What could challenge this read

Despite strong margin and cash-flow growth, operating expenses rose and net debt increased year over year, which could cap upside if financing costs or working-capital needs re-emerge.

Key entities

  • issuer
    Innovative Solutions & Support, Inc.

    Nasdaq-listed company reporting fiscal 2026 Q3 results and financial condition in an SEC 8-K.

  • acquired business
    Aydin Displays

    Acquisition completed in July 2026, described as complementary display technologies for military and defense markets.

  • product platform
    Liberty Flight Deck platform

    Management cites the first production award for primary display and avionics architecture tied to an eVTOL program.

Read at source← All news

Related articles

AUG 14
$ISSCMed

Innovative Aerosystems (ISSC) Q3 2026 Earnings Call Transcript

Innovative Aerosystems (ISSC) reported Q3 FY2026 results in an earnings call. The company said revenue rose about 11% to $20.7 million, with net income of $4.5 million ($0.25 diluted share). Gross margin rose to nearly 52% and adjusted EBITDA grew about 75%. It also discussed the Aiden Displays acquisition, an eVTOL OEM contract, and a Nasdaq ticker change to IA on Aug. 18.

yahoo.com8 min
JUL 21
$ISSCLow

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC): Completion of Acquisition or Disposition of Assets

INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-2.1 2 tm2620924d1_ex2-1.htm EXHIBIT 2.1 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. Exhibit 2.

SEC EDGAR 8-K2 min
AUG 14
$ARAIMed

Arrive AI (ARAI) Q2 2026 Earnings Call Transcript

Arrive AI (ARAI) held its Q2 2026 earnings call. Management reported revenue of $14.7 million, a net loss of $14.1 million, and non-GAAP net loss of $4.3 million. Cash and liquid investments were $5.1 million at June 30, with about $1.1 million monthly burn. The company outlined AP3 Plus shipments, a 2027 ramp, and financing capacity via an S-3 and $15 million ATM.

fool.com7 min
AUG 14
$RMTIMedAI 8/10

Rockwell Medical (RMTI) Q2 2026 Earnings Call Transcript

Rockwell Medical (RMTI) reported Q2 2026 net sales of $17.8 million, up 11% year over year, with gross profit $3.2 million and gross margin expanding to 18%. Net loss improved to $1.2 million, and operating cash flow turned positive at $2.1 million. FY 2026 guidance: revenue $70 million to $75 million, gross margin 18% to 22%, and adjusted EBITDA $1 million to $2 million. The company completed a 1-for-10 reverse split for Nasdaq bid-price compliance.

fool.com7 min
AUG 14
$SPRYMed

ARS Pharmaceuticals Q2 Earnings Call Highlights

ARS Pharmaceuticals (NASDAQ:SPRY) said it expanded its field sales force and will target high-value prescribers, noting neffy has about 8% market share in the field-targeted universe versus ~1% in non-targeted. Commercial coverage is 90%. Q2 operating expenses were $95.1M. ARS expects cash-flow breakeven by end-2027 and Phase IIb CSU interim data in Q1 2027.

yahoo.com6 min